Cargando…
Statin-associated side effects in patients attending a lipid clinic: evidence from a 6-year study
INTRODUCTION: There is conflicting evidence regarding the actual incidence of statin-associated side effects in clinical practice. We aimed to record the incidence of statin-associated side effects in the setting of a lipid clinic. We focused on clinically relevant liver enzyme increase and statin-a...
Autores principales: | Barkas, Fotios, Adamidis, Petros, Koutsogianni, Amalia-Despoina, Liamis, George, Liberopoulos, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487797/ https://www.ncbi.nlm.nih.gov/pubmed/36161219 http://dx.doi.org/10.5114/amsad.2021.111313 |
Ejemplares similares
-
Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin–Therapy: A 6-Year Retrospective Study
por: Anastasiou, Georgia, et al.
Publicado: (2023) -
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2023) -
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2022) -
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
por: Barkas, Fotios, et al.
Publicado: (2021) -
Statin escape phenomenon: Fact or fiction?
por: Barkas, Fotios, et al.
Publicado: (2017)